Skip to main content
. 2010 Oct 22;12(Suppl 2):S2. doi: 10.1186/bcr2573

Figure 1.

Figure 1

Progression-free survival for patients treated with ixabepilone plus capecitabine. Kaplan-Meier progression-free survival curve from a phase III trial of ixabepilone plus capecitabine for metastatic breast cancer patients progressing after anthracycline and taxane treatment [88]. Reprinted with permission from Journal of Clinical Oncology.